News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
861,506 Results
Type
Article (87471)
Company Profile (806)
Press Release (773207)
Multimedia
Podcasts (175)
Webinars (28)
Section
Business (233068)
Career Advice (4140)
Deals (39800)
Drug Delivery (138)
Drug Development (91261)
Employer Resources (203)
FDA (18287)
Job Trends (17403)
News (397428)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (126)
Alliances (56980)
ALS (147)
Alzheimer's disease (1684)
Antibody-drug conjugate (ADC) (256)
Approvals (18317)
Artificial intelligence (499)
Autoimmune disease (84)
Automation (27)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (163)
Biotechnology (485)
Bladder cancer (135)
Brain cancer (53)
Breast cancer (514)
Cancer (4036)
Cardiovascular disease (345)
Career advice (3560)
Career pathing (38)
CAR-T (250)
CDC (57)
Cell therapy (693)
Cervical cancer (33)
Clinical research (75617)
Collaboration (1408)
Company closure (4)
Compensation (940)
Complete response letters (60)
COVID-19 (2960)
CRISPR (81)
C-suite (600)
Cystic fibrosis (139)
Data (4625)
Decentralized trials (2)
Denatured (63)
Depression (112)
Diabetes (456)
Diagnostics (7095)
Digital health (37)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (238)
Drug pricing (191)
Drug shortages (36)
Duchenne muscular dystrophy (204)
Earnings (98900)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133122)
Executive appointments (994)
FDA (20790)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1271)
Gene editing (173)
Generative AI (50)
Gene therapy (550)
GLP-1 (1024)
Government (5386)
Grass and pollen (7)
Guidances (351)
Healthcare (20938)
HIV (48)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (245)
Immuno-oncology (21)
Indications (53)
Infectious disease (3208)
Inflammatory bowel disease (188)
Inflation Reduction Act (16)
Influenza (101)
Intellectual property (192)
Interviews (816)
IPO (17928)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (17)
Labor market (80)
Layoffs (641)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (13)
Lung cancer (581)
Lymphoma (268)
Machine learning (31)
Management (66)
Manufacturing (647)
MASH (141)
Medical device (14883)
Medtech (14908)
Mergers & acquisitions (22759)
Metabolic disorders (1165)
Multiple sclerosis (138)
NASH (23)
Neurodegenerative disease (233)
Neuropsychiatric disorders (62)
Neuroscience (2734)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (59)
Obesity (563)
Opinion (314)
Ovarian cancer (136)
Pain (168)
Pancreatic cancer (173)
Parkinson's disease (243)
Partnered (30)
Patents (423)
Patient recruitment (323)
Peanut (57)
People (66295)
Pharmaceutical (145)
Pharmacy benefit managers (27)
Phase I (23326)
Phase II (32824)
Phase III (24733)
Pipeline (2756)
Policy (295)
Postmarket research (3554)
Preclinical (10522)
Press Release (72)
Prostate cancer (202)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (684)
Real estate (7422)
Recruiting (79)
Regulatory (28051)
Reports (65)
Research institute (2692)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (137)
Series A (211)
Series B (158)
Service/supplier (30)
Sickle cell disease (81)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (41)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (96)
The Weekly (110)
Vaccines (1055)
Venture capital (67)
Weight loss (398)
Women's health (59)
Worklife (21)
Date
Today (36)
Last 7 days (697)
Last 30 days (2580)
Last 365 days (33456)
2025 (27042)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (80)
Alaska (7)
Arizona (304)
Arkansas (14)
Asia (51009)
Australia (8964)
California (9579)
Canada (2888)
China (917)
Colorado (405)
Connecticut (427)
Delaware (273)
Europe (117191)
Florida (1409)
Georgia (317)
Hawaii (3)
Idaho (67)
Illinois (816)
India (52)
Indiana (466)
Iowa (20)
Japan (329)
Kansas (125)
Kentucky (38)
Louisiana (21)
Maine (78)
Maryland (1289)
Massachusetts (7185)
Michigan (315)
Minnesota (566)
Mississippi (4)
Missouri (122)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (79)
New Jersey (2655)
New Mexico (32)
New York (2600)
North Carolina (1421)
North Dakota (10)
Northern California (4356)
Ohio (300)
Oklahoma (22)
Oregon (50)
Pennsylvania (1988)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (50)
South Dakota (1)
Southern California (3656)
Tennessee (150)
Texas (1505)
United States (35332)
Utah (284)
Virginia (250)
Washington D.C. (84)
Washington State (824)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
There are 861,506 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Phathom Pharmaceuticals Announces Publication of Data from Phase 3 pHalcon-NERD-301 Study Showing VOQUEZNA® (vonoprazan) Improved Nocturnal GERD Symptoms in Patients with Non-Erosive Reflux Disease
October 27, 2025
·
13 min read
Press Releases
Data presented at ACR Convergence 2025 highlight Sobi’s commitment to advancing care across rare and underserved inflammatory conditions
October 27, 2025
·
16 min read
Press Releases
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
October 27, 2025
·
6 min read
Press Releases
Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigator-Initiated Trial Presented at ACR Convergence 2025
October 27, 2025
·
8 min read
Press Releases
Novartis showcases significant immunology advancements in ACR congress with new data in complex autoimmune diseases
October 27, 2025
·
8 min read
Press Releases
Quell Therapeutics to Unveil Promising Data for QEL-005, a Novel CAR-Treg Cell Therapy for Complex Autoimmune Diseases, at ACR Convergence 2025
October 27, 2025
·
4 min read
Press Releases
BIMZELX® (bimekizumab-bkzx) Three-Year Rheumatology Data at ACR 2025 Demonstrated Sustained Inflammation Control in Psoriatic Arthritis and Axial Spondyloarthritis
October 27, 2025
·
26 min read
Press Releases
Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3Kα Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing Hyperglycemia
October 27, 2025
·
7 min read
Press Releases
Avacta presents first preclinical data from dual payload pre|CISION® medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets
October 27, 2025
·
6 min read
Press Releases
Bristol Myers Squibb Presents Encouraging Data from Phase 1 Breakfree-1 Study of CD19 NEX-T™ CAR T Cell Therapy in Three Chronic Autoimmune Diseases at ACR Convergence 2025
October 27, 2025
·
11 min read
1 of 86,151
Next
